Cargando…

Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus

PURPOSE: To evaluate the corneal pachymetric and topographic parameters of systemic Lupus Erythematosus (SLE) patients using Dual Scheimpflug Imaging. METHODS: This observational cross-sectional controlled study included the right eye of 30 SLE patients and 30 age-matched controls. Corneal measureme...

Descripción completa

Detalles Bibliográficos
Autores principales: Eissa, Iman M, Nassar, Ghada A, Arfeen, Shaimaa A, Dahab, Ahmed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053818/
https://www.ncbi.nlm.nih.gov/pubmed/32184547
http://dx.doi.org/10.2147/OPTH.S234568
_version_ 1783503114055188480
author Eissa, Iman M
Nassar, Ghada A
Arfeen, Shaimaa A
Dahab, Ahmed A
author_facet Eissa, Iman M
Nassar, Ghada A
Arfeen, Shaimaa A
Dahab, Ahmed A
author_sort Eissa, Iman M
collection PubMed
description PURPOSE: To evaluate the corneal pachymetric and topographic parameters of systemic Lupus Erythematosus (SLE) patients using Dual Scheimpflug Imaging. METHODS: This observational cross-sectional controlled study included the right eye of 30 SLE patients and 30 age-matched controls. Corneal measurements were acquired by dual Scheimpflug imaging including anterior and posterior corneal curvatures, central, mid-peripheral corneal thickness (measured at the 5 mm zone) and peripheral pachymetry (measured at the 7 mm zone). SLE disease activity index (SLEDAI) was calculated and correlated with corneal pachymetry. RESULTS: SLE patients had significantly thicker corneal periphery than controls. Mean central corneal pachymetry was 530.4± 27.3 microns (SD) in SLE and 547.5±31.5 microns (SD) in control group, p = 0.032. The corneal periphery – except superiorly – was significantly thicker in SLE patients than controls (p ˂0.001). Nasal peripheral corneal thickness positively correlated with disease activity index SLEDAI (p=0.03). CONCLUSION: SLE patients present with thicker corneal periphery than controls characteristically sparing the superior quadrant. Possible corneal photosensitivity leading to peripheral immune complex deposition as well as flatter posterior corneal surface at the periphery are proposed explanations for these findings.
format Online
Article
Text
id pubmed-7053818
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70538182020-03-17 Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus Eissa, Iman M Nassar, Ghada A Arfeen, Shaimaa A Dahab, Ahmed A Clin Ophthalmol Original Research PURPOSE: To evaluate the corneal pachymetric and topographic parameters of systemic Lupus Erythematosus (SLE) patients using Dual Scheimpflug Imaging. METHODS: This observational cross-sectional controlled study included the right eye of 30 SLE patients and 30 age-matched controls. Corneal measurements were acquired by dual Scheimpflug imaging including anterior and posterior corneal curvatures, central, mid-peripheral corneal thickness (measured at the 5 mm zone) and peripheral pachymetry (measured at the 7 mm zone). SLE disease activity index (SLEDAI) was calculated and correlated with corneal pachymetry. RESULTS: SLE patients had significantly thicker corneal periphery than controls. Mean central corneal pachymetry was 530.4± 27.3 microns (SD) in SLE and 547.5±31.5 microns (SD) in control group, p = 0.032. The corneal periphery – except superiorly – was significantly thicker in SLE patients than controls (p ˂0.001). Nasal peripheral corneal thickness positively correlated with disease activity index SLEDAI (p=0.03). CONCLUSION: SLE patients present with thicker corneal periphery than controls characteristically sparing the superior quadrant. Possible corneal photosensitivity leading to peripheral immune complex deposition as well as flatter posterior corneal surface at the periphery are proposed explanations for these findings. Dove 2020-02-28 /pmc/articles/PMC7053818/ /pubmed/32184547 http://dx.doi.org/10.2147/OPTH.S234568 Text en © 2020 Eissa et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Eissa, Iman M
Nassar, Ghada A
Arfeen, Shaimaa A
Dahab, Ahmed A
Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
title Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
title_full Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
title_fullStr Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
title_full_unstemmed Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
title_short Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
title_sort evaluation of central and peripheral corneal thicknesses in patients with systemic lupus erythematosus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053818/
https://www.ncbi.nlm.nih.gov/pubmed/32184547
http://dx.doi.org/10.2147/OPTH.S234568
work_keys_str_mv AT eissaimanm evaluationofcentralandperipheralcornealthicknessesinpatientswithsystemiclupuserythematosus
AT nassarghadaa evaluationofcentralandperipheralcornealthicknessesinpatientswithsystemiclupuserythematosus
AT arfeenshaimaaa evaluationofcentralandperipheralcornealthicknessesinpatientswithsystemiclupuserythematosus
AT dahabahmeda evaluationofcentralandperipheralcornealthicknessesinpatientswithsystemiclupuserythematosus